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Abstract The interaction of plant toxin ricin and MLI binding 
subunits to liposomes containing monosialoganglioside (GM1), 
bearing a terminal galactose residue, has been examined as a 
possible receptor model. For the first time we demonstrate that 
ricin B-chain but not ricin provokes liposome aggregation at 10 
M% GM1 concentration, whereas in the presence of either ricin 
A-chain or galactose the aggregation is inhibited. The B-subunit 
of plant toxin MLI from Viscum album has similar lectin 
specificity and activity but cannot aggregate GM1 liposomes. 
The ability of the B-chain to aggregate liposomes adds a new 
crucial step in the toxin transmembrane penetration mechanism. 
We demonstrate here possible ricin B-chain interactions with 
membranes proceeding via two sites, namely (a) a galactose-
binding domain and (b) a hydrophobic interchain domain. In 
close contact with two phospholipid bilayers, ricin B-chain may 
determine the geometry of the fusion site. These events can 
provoke A-chain translocation which follows membrane fusion. 
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1. Introduction 
The plant toxin ricin, a type II ribosome-inactivating pro-
tein (RIP II), comprises two polypeptide chains, A and B, 
linked by a disulfide bond [1]. The A-subunit (RTA) is a 
highly specific A^-glycosidase that modifies 28S R N A of the 
60S ribosome subunit. Ricin B-chain (RTB) is a galactose-
specific lectin, with two carbohydrate-binding sites which 
have been characterized structurally by X-ray crystallographic 
studies at 2.5 A resolution [2]. The B-chain not only helps to 
locate the A-chain prior to release, by binding to carbohy-
drates on the cell surface, but also plays an essential role in 
promoting the t ransmembrane penetration of the A-chain into 
the cytosol [3]. During this process both the A- and B-chains 
interact with phospholipid bilayers to reach the intracellular 
target [4]. It has been shown that the ricin A-chain transloca-
tion is ATP-mediated [5]. The protein components of intra-
cellular organelle membranes are required for R T A transloca-
tion [6]. Studies with GM1-containing membrane models 
demonstrated that native ricin and its A- and B-chains deeply 
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Abbreviations: RTB, ricin B-chain; RTA, ricin A-chain; MLI, 
mistletoe lectin I; MLIB, mistletoe lectin I B-chain; PBS, phosphate-
buffered saline; BSA, bovine serum albumin; DMPC, dimyristoyl-
phosphatidylcholine; IC50, toxin concentration causing 50% inhibition 
of [3H]thymidine incorporation into cells 
penetrate the membrane, especially at p H 4.5 [7]. The re-
combinant chimeric protein obtained by fusing together 
R T A and a fragment of protein G of the vesicular stomatitis 
virus interacts with phospholipid vesicles with 15-fold faster 
kinetics than native R T A at acidic p H [8]. 
Toxins with intracellular sites of action, like ricin and MLI, 
are ideal model proteins for studying lipid-protein interactions 
and protein transmembrane penetration that occur during the 
internalization of physiologically active molecules. While the 
toxicity of RIPs II against target cells is well characterized 
biochemically [1,2], the molecular mechanism of its transloca-
tion remains unclear. 
In this study ricin and MLI B-chain activity has been ex-
amined in lipid bilayers, both with and without toxin recep-
tors. The experiments were performed at both neutral and 
acid p H in order to model different cell compartments . It 
has been shown previously that ricin B-chain itself undergoes 
structural transitions under acid conditions (the mid-point of 
the transition being at pH 4.5), whereas the ricin A-subunit 
conformation is not p H dependent [9]. We compared the abil-
ity to aggregate G M 1 liposomes of R T B and B-chain of plant 
toxin M L I (MLIB) from Viscum album. The structure and 
mechanism of action of M L I and ricin are similar [1,2]. Cy-
totoxic activity of the holotoxins was compared according to 
the ability of the B-chains to interact with liposomes. 
2. Materials and methods 
Ricin was extracted from Ricinus communis seeds together with ricin 
agglutinin and subsequently isolated and purified [10]. Isolated A- and 
B-subunits were also prepared as previously described [10]. The A-
subunit was additionally passed through a Sepharose 4B column with 
fixed asialophetuin in order to completely eliminate traces of the B-
subunit. MLI was extracted from Viscum album leaves and A- and B-
subunits were purified as previously described [11]. The purity of these 
preparations was estimated using gradient SDS-PAGE (7-22%) and 
tested for cytotoxicity on the T-lymphoblast Jurkat cell line by meas-
uring the inhibition of [3 HJthymidine incorporation [10]. RTB-RTA 
reassociation was prepared as described in [12]. GM1 ganglioside was 
kindly provided by Dr. N.V. Prokasova of Moscow Cardiology Re-
search Center, Russia. 
Small unilamellar liposomes were produced by drying dimyristoyl-
phosphatidylcholine (DMPC) without and with GM1 ganglioside sol-
utions in varying molar ratio, on a rotor evaporator. Subsequently the 
mixture was treated for 5 min with ultrasound in a buffer containing 
5 mM TES, 140 mM NaCl, 1 mM EDTA, at pH 7.5 in a nitrogen 
atmosphere (50 W, 22-28 kHz) at +4°C and incubated for 2 h at 
+28°C. 
Phase transition and liposome aggregation were monitored from 
optical density measurements at a wavelength of 350 nm using a 
UV-VIS spectrophotometer (Perkin & Elmer, Germany) as previously 
described [10]. The concentration of lipids in liposome solution was 
5 mM in phase transition experiments and 0.25 mM in aggregation 
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experiments. All liposome aggregation experiments were carried out at 
+28°C. 
3. Results and discussion 
Fig. 1 shows the absorbency measurement of a DMPC-lip-
osome suspension, in the presence of ricin B-chain, with in-
creasing temperature and different GMl concentrations. The 
mid-point of the phase transition corresponds to about 24°C. 
At GMl concentrations of 2, 4 and 8 M% a smoothing of the 
phase transition and an increase of the corresponding temper-
ature range over which it took place were observed. This 
strongly suggests a cooperative decrease in the ordering of 
the lipid bilayer [13]. Addition of either ricin or its A-subunit 
does not cause significant changes in the absorbency of the 
suspension at the phase transition temperature at pH 7.5 and 
4.5 (data not shown). At a ganglioside/phospholipid molar 
ratio of 10% after the addition of RTB a steep increase 
of the suspension absorbency was observed, associated 
with a transition to the liquid crystal phase and indicative 
of liposome aggregation. Aggregation did not take place 
when administering 50 mM galactose to the incubation mix-
ture. 
The rate of DMPC/GM1-liposome aggregation depends on 
the concentration of ricin B-chain in the incubation medium 
(Fig. 2). MLIB does not affect liposome aggregation. Addition 
of ricin to the liposome suspension up to a concentration of 
0.2 mg/ml did not cause liposome aggregation and completely 
inhibited liposome aggregation induced by RTB (data not 
shown). Fig. 3 shows the effect of ricin A-chain on RTB-
induced DMPC/GM1-liposome aggregation. Ricin B-chain 
did not provoke liposome aggregation in the presence of 
RTA because of the dimerization of RTB and RTA (checked 
by size exclusion HPLC, data not shown). In control experi-
ments the liposome aggregation with B-chain was not affected 
by the presence of IgG, chymotrypsin or BSA. Data of cyto-
toxic activity of the holotoxins are shown in Fig. 4. Compar-
ing the IC50 value the native ricin is 25 times more toxic than 
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Fig. 2. Influence of ricin and MLI B-chain on DMPC-liposome ag-
gregation: (a) DMPC-liposomes with 10 M% GMl+0.06 mg/ml ri-
cin B-chain; (b) DMPC-liposomes with 10 M% GMl+0.03 mg/ml 
ricin B-chain; (c) DMPC-liposomes without GMl+0.03 mg/ml ricin 
B-chain; (d) DMPC-liposomes with 10 M% GM1+0.06 mg/ml MLI 
B-chain. The arrow indicates addition of ricin B-chain; 'Gal' indi-
cates addition of galactose (50 mM). 
native MLI. The amount of binding sites and association 
constant with Jurkat cells was the same as previously shown 
[14]. 
The fluorescence method has been used previously to inves-
tigate the interaction of ricin and its isolated subunits with 
GMl-containing model membranes [7,15]. This indicated that 
protein-liposome interaction evokes changes in the parameters 
of both intrinsic protein fluorescence and fluorescence of the 
covalently bound dansyl. The association constants were dif-
ferent for intact ricin and its subunits and also depended on 
the liposome composition and pH. It was demonstrated that 
the interaction of ricin subunits with liposome is accounted 
for not only by receptor centers but also by other hydropho-
bic regions of ricin that are inaccessible in the native toxin and 
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Fig. 1. Influence of GMl concentration on the interaction of 
DMPC-liposomes and ricin B-chain (0.03 mg/ml) at the phase tran-
sition temperature. (1) DMPC-liposomes without GMl; (2) 2 M% 
GMl; (3) 4 M% GMl; (4) 8 M% GMl; (5) 10 M% GMl. 
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Fig. 3. Influence of ricin A-chain on liposome aggregation: (a) lipo-
somes+0.03 mg/ml ricin B-chain; (b) liposomes+0.03 mg/ml ricin A-
chain+0.03 mg/ml ricin B-chain, pH 7.5; (c) liposomes+0.2 mg ricin 
A-chain+0.03 mg/ml ricin B-chain, pH 5.5. The arrow indicates ad-
dition of ricin B-chain; 'Gal' indicates addition of galactose (50 
mM). 
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Fig. 4. Cytotoxic activity of ricin (1, 3) and MLI (2, 4) on Jurkat 
cells in the presence of 50 mM galactose (3, 4) or without (1, 2). 
unique ability of RTB to aggregate model phospholipid 
vesicles. A-subunits of the toxins have approximately the 
same enzymatic activity [19] and structural stability [20]. 
MLIB cannot aggregate liposomes because of low hydropho-
bicity and/or inability to interact with receptors by two car-
bohydrate-specific centers. Also the cytotoxic action of RIP II 
proteins is greater than RIP I owing to the existence of a 
binding subunit that can not only bind to receptor but also 
obligate A-chain passage to cytosol by interaction with intra-
cellular membranes. 
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